FDA daily for Sunday, October 4, 2026
21 FDA records across 2 sections.
Drug shortagesCovers FDA's Sat, Oct 3 (yesterday)20
- Methotrexate Sodium Injection
Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30) — Accord Healthcare Inc.
- Azacitidine Injection
Azacitidine, Injection, 100 mg (NDC 16729-306-10) — Accord Healthcare Inc.
- Atropine Sulfate Injection
Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) — Accord Healthcare Inc.
- Carboplatin Injection
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33) — Accord Healthcare Inc.
- Clonazepam Tablet
Clonazepam, Tablet, .5 mg (NDC 16729-136-00) — Accord Healthcare Inc.
- Methotrexate Sodium Injection
Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35) — Accord Healthcare Inc.
- Clonazepam Tablet
Clonazepam, Tablet, 1 mg (NDC 16729-137-00) — Accord Healthcare Inc.
- Carboplatin Injection
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12) — Accord Healthcare Inc.
- Atropine Sulfate Injection
Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) — Accord Healthcare Inc.
- Clonazepam Tablet
Clonazepam, Tablet, .5 mg (NDC 16729-136-16) — Accord Healthcare Inc.
- Carboplatin Injection
Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31) — Accord Healthcare Inc.
- Furosemide Injection
Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43) — Accord Healthcare Inc.
Showing 12 of 20. Search the rest in openFDA.
Label changesCovers FDA's Sun, Sep 20 (two weeks ago)1
- MINOXIDIL EXTRA STRENGTH (FOR MEN)
FlexiGo Inc
How the FDA Daily Is WrittenSources, dates and what gets flagged
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.
Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.
Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.